Innate-immune crosstalk orchestrates T cell-mediated rejection in kidney transplants - Report - MDSpire

Innate-immune crosstalk orchestrates T cell-mediated rejection in kidney transplants

  • By

  • Yuyun Hu

  • Zhiqiang Chen

  • Yujun Liang

  • Zhixuan Wu

  • Yijian Zhang

  • Junyu Guo

  • Chunqiang Dong

  • Guanmiao Chen

  • Michael Williams

  • Emily Johnson

  • Min He

  • Wei Du

  • Boqian Wang

  • July 7, 2026

  • 0 min

Share

Clinical Report: Crosstalk in Innate Immunity Influences T Cell-Driven Rejection in Renal Transplants

Overview

This study explores the cellular and molecular mechanisms of T cell-mediated rejection (TCMR) in kidney transplants, highlighting the role of innate immune cells in amplifying adaptive immune responses.

Background

T cell-mediated rejection (TCMR) is a significant barrier to long-term kidney allograft survival, with approximately 40% of patients responding poorly to standard therapies. Understanding the mechanisms of TCMR is critical for developing new diagnostic and therapeutic strategies.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

  • Identification of an NQO1+NDUFS4+ proximal tubular subset linked to metabolic remodeling under inflammatory stress.
  • Presence of an S100A8+ macrophage subset with a pro-inflammatory phenotype that recruits CD8+ T and NKT cells.
  • CCL4L2+ NKT cells exacerbate rejection by enhancing immune recruitment and cytotoxic functions.
  • Extensive communication networks between innate and adaptive immune cells through chemokine and inflammatory axes.
  • DUSP1+ effector CD8+ T cells are selectively enriched in TCMR and may be associated with graft injury.

Clinical Implications

The findings highlight the role of innate immune cell interactions in TCMR.

Conclusion

This study provides a single-cell atlas of the TCMR immune microenvironment.

Related Resources & Content

  1. Frontiers in Immunology, 2026 -- The CD40-CD154 axis in transplantation: from immunobiology to therapeutic targeting
  2. Frontiers in Immunology, 2026 -- Highly sensitized kidney transplant candidates: integrating acceptable mismatch, desensitization, imlifidase, and emerging immune-cell targeting strategies
  3. Frontiers in Immunology, 2026 -- Analysis of the predictive value of Th17/Treg cells and cytokines for the risk of infection after kidney transplantation
  4. The Banff 2024 Kidney Meeting Report: Rejection as a spectrum of phenotypes and focus on differential diagnostic reasoning - PubMed
  5. Frontiers in Immunology — Timing matters: tacrolimus intra-patient variability within the initial seven months forecasts de novo DSA and subsequent rejection in a Chinese kidney transplant cohort
  6. The Banff 2024 Kidney Meeting Report: Rejection as a spectrum of phenotypes and focus on differential diagnostic reasoning - PubMed
  7. Frontiers | Steroid pulse therapy for acute T-cell-mediated rejection after kidney transplantation: mechanisms, evidence, and unresolved questions
  8. Spatial transcriptomics reveals distinct role of monocytes/macrophages with high FCGR3A expression in kidney transplant rejections - PubMed

Original Source(s)

Related Content